Ace levels in sarcoidosis
Pro Research Analysisby 
Searched over 200M research papers
Serum ACE Levels as a Biomarker in Sarcoidosis
Serum angiotensin-converting enzyme (ACE) levels are often elevated in patients with active sarcoidosis, making ACE a commonly used biomarker in the diagnostic process. Studies consistently show that patients with sarcoidosis have higher median ACE levels compared to those without the disease, and that ACE levels tend to decrease with disease resolution or corticosteroid therapy 1236. However, the clinical utility of ACE as a diagnostic and monitoring tool is limited by several factors.
Diagnostic Sensitivity, Specificity, and Cut-off Values for ACE in Sarcoidosis
The sensitivity and specificity of elevated ACE levels for diagnosing sarcoidosis are generally low. Reported sensitivities range from about 21% to 67%, while specificities can be higher, up to 89.9% in some studies 1459. The positive predictive value (PPV) of an elevated ACE is low (as little as 12–25%), but the negative predictive value (NPV) is relatively high (about 94–95%), meaning a normal ACE level makes sarcoidosis less likely, but an elevated level is not definitive for diagnosis 45.
Several studies have suggested that the commonly used cut-off values for ACE may be too high, resulting in missed diagnoses. Lowering the cut-off value increases sensitivity but reduces specificity and PPV, so careful interpretation is needed, especially in patients with ACE levels at the higher end of the normal range 19.
ACE Levels and Disease Activity
ACE levels are generally higher in patients with active sarcoidosis and tend to normalize with disease remission or corticosteroid treatment 23. However, the correlation between ACE levels and disease activity is inconsistent, and some studies have found no significant difference in ACE levels between active and remission phases . Serial monitoring of ACE can be useful for tracking therapeutic response in some patients, but it should not be relied upon as the sole indicator of disease activity 236.
Factors Affecting ACE Levels: Medications and Genetic Polymorphisms
ACE inhibitor medications significantly lower serum ACE levels, which can confound interpretation in patients being treated for hypertension or other conditions 16. Additionally, genetic polymorphisms in the ACE gene (insertion/deletion variants) influence baseline ACE levels, with the DD genotype associated with the highest levels and the II genotype with the lowest. Adjusting normal ranges for ACE based on genotype can improve diagnostic sensitivity 810.
Specificity and Limitations of ACE as a Sarcoidosis Marker
While elevated ACE is most commonly associated with sarcoidosis, it can also be seen in other conditions such as Gaucher’s disease, non-Hodgkin’s lymphoma, cirrhosis, and interstitial lung disease 24. No other granulomatous disease consistently shows the same degree of ACE elevation as sarcoidosis, but the overlap with other diseases limits its specificity 2345.
Advances in ACE Testing: ACE Phenotyping
Newer approaches, such as ACE phenotyping and immunoreactivity assays, may improve the sensitivity and specificity of ACE testing for systemic and extrapulmonary sarcoidosis by distinguishing ACE derived from granuloma macrophages . These methods are still under investigation but show promise for more accurate noninvasive detection.
Conclusion
Serum ACE levels are frequently elevated in active sarcoidosis and can aid in diagnosis and monitoring, but their sensitivity and specificity are limited. Interpretation of ACE results should consider medication use, genetic background, and the presence of other diseases. Lowering the diagnostic cut-off can improve sensitivity but reduces specificity. Newer phenotyping techniques may enhance diagnostic accuracy in the future. Overall, ACE should be used as part of a broader clinical assessment rather than as a standalone diagnostic tool for sarcoidosis 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic